Noel Donnelly
CIK: 0001922546
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (14 total)
- Mar 4, 2026PEPG
PepGen Inc.
Sale(S)Direct52 shares at avg. $6.33$328.9 - Mar 4, 2026PEPG
PepGen Inc.
Sale(S)Direct2K shares at avg. $6.23$13K - Mar 1, 2026PEPG
PepGen Inc.
Award(A)Direct76.8K shares- - Nov 4, 2025PEPG
PepGen Inc.
Award(A)DirectStock Option (Right to Buy)
144K shares- - Nov 4, 2025PEPG
PepGen Inc.
Disposition(D)DirectStock Option (Right to Buy)
144K shares- - Nov 4, 2025PEPG
PepGen Inc.
Award(A)DirectStock Option (Right to Buy)
144K shares- - Nov 4, 2025PEPG
PepGen Inc.
Disposition(D)DirectStock Option (Right to Buy)
144K shares- - Nov 4, 2025PEPG
PepGen Inc.
Disposition(D)DirectStock Option (Right to Buy)
203.3K shares- - Nov 4, 2025PEPG
PepGen Inc.
Award(A)DirectStock Option (Right to Buy)
203.3K shares- - Nov 4, 2025PEPG
PepGen Inc.
Disposition(D)DirectStock Option (Right to Buy)
169K shares- - Nov 4, 2025PEPG
PepGen Inc.
Award(A)DirectStock Option (Right to Buy)
169K shares- - Mar 3, 2025PEPG
PepGen Inc.
Award(A)Direct23.3K shares- - Feb 26, 2025PEPG
PepGen Inc.
Sale(S)Direct1.5K shares at avg. $1.68$3K - Feb 24, 2025PEPG
PepGen Inc.
Award(A)Direct3.2K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 4, 2026 |  PEPG PepGen Inc. | Sale(S) | 52 | $6.33 | $329 | Direct |
| Mar 4, 2026 | PEPG PepGen Inc. | Sale(S) | 2,032 | $6.23 | $12,659 | Direct |
| Mar 1, 2026 | PEPG PepGen Inc. | Award(A) | 76,793 | - | $0 | Direct |
| Nov 4, 2025 | PEPG PepGen Inc. | Award(A) Stock Option (Right to Buy) | 144,000 | - | - | Direct |
| Nov 4, 2025 | PEPG PepGen Inc. | Disposition(D) Stock Option (Right to Buy) | 144,000 | - | - | Direct |
| Nov 4, 2025 | PEPG PepGen Inc. | Award(A) Stock Option (Right to Buy) | 144,000 | - | - | Direct |
| Nov 4, 2025 | PEPG PepGen Inc. | Disposition(D) Stock Option (Right to Buy) | 144,000 | - | - | Direct |
| Nov 4, 2025 | PEPG PepGen Inc. | Disposition(D) Stock Option (Right to Buy) | 203,339 | - | - | Direct |
| Nov 4, 2025 | PEPG PepGen Inc. | Award(A) Stock Option (Right to Buy) | 203,339 | - | - | Direct |
| Nov 4, 2025 | PEPG PepGen Inc. | Disposition(D) Stock Option (Right to Buy) | 169,037 | - | - | Direct |
| Nov 4, 2025 | PEPG PepGen Inc. | Award(A) Stock Option (Right to Buy) | 169,037 | - | - | Direct |
| Mar 3, 2025 | PEPG PepGen Inc. | Award(A) | 23,283 | - | - | Direct |
| Feb 26, 2025 | PEPG PepGen Inc. | Sale(S) | 1,527 | $1.68 | $2,565 | Direct |
| Feb 24, 2025 | PEPG PepGen Inc. | Award(A) | 3,200 | - | - | Direct |
1-14 of 14 transactions
About Donnelly Noel
Donnelly Noel (SEC CIK 0001922546) files insider reports with the SEC as Director of Radiopharm Theranostics Ltd (RADX) and Chief Financial Officer of PepGen Inc. (PEPG).
Signal8 holds 6 ownership filings by Donnelly Noel (1 Form 3, 5 Form 4), filed between Feb 26, 2025 and Apr 1, 2026. Those filings report 14 transactions, from Feb 24, 2025 to Mar 4, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Donnelly Noel's filings is in BOSTON, MA.
Recent filings by Donnelly Noel
- Mar 4, 2026: Open-market sales of PEPG shares (2 lines, Form 4, code S).
- Mar 1, 2026: Grant or award of PEPG shares (Form 4, code A).
- Nov 4, 2025: Grant or award of PEPG derivative securities (Form 4, code A).
- Nov 4, 2025: Disposition to issuer transaction of PEPG derivative securities (Form 4, code D).
- Nov 4, 2025: Grant or award of PEPG derivative securities (Form 4, code A).
Other insiders filing for Radiopharm Theranostics Ltd (RADX)
- Voliotis Dimitris, Chief Medical Officer
- HOPPER PAUL, Director
- Turner Ian Lawrence, Director
- Goodwin Bruce Michael, Director